Module 18

Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
General Properties
Below we list the number of gene sets from which the module was composed was originally composed, and the number of genes and experiments that it contains. Clicking on the number of genes will display a detailed list of all the genes in the module. Clicking on the number of experiments will display a detailed list of all the experiments in the module.
Num gene sets: 2
Num genes: 451 (see 2841 additional genes for this module)
Num experiments: 970 (312 induced, 658 repressed)
Parent module: 52
Children modules: None


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Gene sets
Below we list the gene sets from which the module was originally composed. Clicking on a gene set will display all the genes associated with that gene set. Also listed are all the other modules in which the gene set participates.
A2058_2
A2058_1


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched clinical annotations
For each of the clinical annotations, we tested whether it was enriched in the set of arrays in which the module is significantly induced (or repressed). Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of induced (or repressed) module's arrays in which they appear. We also show the fraction of the module's induced (or repressed) arrays with the given annotation ('Hits (%)' column). For completeness, we also list the total number of relevant induced arrays in the module ('Module hits in category' column), total number of arrays in the compendium in which the corresponding annotation is present ('Arrays in annotation' column), and the total number of relevant arrays in the compendium ('Arrays' column). Note that the 'relevant' arrays may be different for each annotation, since it includes only arrays in which the annotation was relevant (i.e., present or not present) and excludes arrays where the value of the annotation was not known. Rows that correspond to annotations that were enriched in the induced arrays of the module have a red background, while rows corresponding to annotations enriched in the repressed arrays have a green background. For each annotation, we also list the other modules in which it was enriched.
Clinical annotation Category P-value Hits Hits(%) Module hits in category Arrays in annotation Arrays
Hematologic cancer and cell line (Stimulated PBMC) Stimulated PBMC 2.4e-30 30 88.2 34 30 182
Macrophages (Stimulated PBMC) Stimulated PBMC 2.4e-30 30 88.2 34 30 182
CNS tissue, cancer or cell line (Neuro tumors*) Neuro tumors* 2.0e-16 65 9.8 657 85 1945
Cancer and cell line (Liver cancer) Liver cancer 2.2e-15 60 98.3 61 126 207
CNS cancer or cell line (Neuro tumors*) Neuro tumors* 6.7e-15 61 9.2 657 81 1945
CNS tumor (Neuro tumors*) Neuro tumors* 6.7e-15 61 9.2 657 81 1945
Cancer and cell line (Neuro tumors*) Neuro tumors* 1.2e-13 62 9.4 657 86 1945
Cancer (Neuro tumors*) Neuro tumors* 1.2e-13 62 9.4 657 86 1945
Prostate (Prostate cancer*) Prostate cancer* 3.4e-13 69 10.5 657 101 1945
Chronic lymphocytic leukemia (B lymphoma) B lymphoma 1.2e-11 37 41.5 89 46 245
Leukemia (B lymphoma) B lymphoma 1.2e-11 37 41.5 89 46 245
Leukemia or leukemia cell line (B lymphoma) B lymphoma 1.2e-11 37 41.5 89 46 245
Non-tumor liver tissue (Liver cancer) Liver cancer 6.4e-10 47 65.2 72 76 207
Cell line (B lymphoma) B lymphoma 1.6e-09 11 39.2 28 14 245
Normal lung tissue (Lung cancer) Lung cancer 3.7e-07 19 19.5 97 22 276
Cell line (Liver cancer) Liver cancer 7.3e-07 11 18.0 61 11 207
Hematologic cancer and cell line (Stimulated immune*) Stimulated immune* 1.5e-06 23 7.3 312 53 1945
Hematologic samples and cell lines (Stimulated immune*) Stimulated immune* 1.5e-06 23 7.3 312 53 1945
Macrophages (Stimulated immune*) Stimulated immune* 1.5e-06 23 7.3 312 53 1945
Monocytes (Stimulated immune*) Stimulated immune* 1.5e-06 23 7.3 312 53 1945
Normal tissue (Lung cancer) Lung cancer 1.5e-06 19 19.5 97 23 276
Invasive liver tumor (Liver cancer) Liver cancer 1.6e-06 24 39.3 61 38 207
Cancer (Liver cancer) Liver cancer 2.0e-06 49 80.3 61 115 207
Liver tissue, cancer or cell line (Liver cancer*) Liver cancer* 2.3e-06 56 17.9 312 197 1945
Liver cancer cell line (Liver cancer) Liver cancer 2.8e-06 10 16.3 61 10 207
Hematologic cancer and cell line (NCI60) NCI60 3.0e-06 13 27.0 48 14 139
Hematologic samples and cell lines (NCI60) NCI60 3.0e-06 13 27.0 48 14 139
Leukemia cell line (NCI60) NCI60 3.0e-06 13 27.0 48 14 139
Adenocarcinoma (Liver cancer) Liver cancer 9.1e-06 43 70.4 61 97 207
Grade 3 (Breast cancer) Breast cancer 2.0e-05 12 100 12 38 85
Hematologic samples (B lymphoma) B lymphoma 5.1e-05 17 19.1 89 22 245
Follicular lymphoma (B lymphoma) B lymphoma 6.6e-05 20 22.4 89 28 245
Melanoma cell line (NCI60) NCI60 8.0e-05 11 32.3 34 16 139
Melanoma tumor or cell line (NCI60) NCI60 8.0e-05 11 32.3 34 16 139
Renal tissue (Various tumors) Various tumors 9.8e-05 10 15.6 64 10 154
B. petrussis 537 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 0.0001 5 20 25 5 144
B. petrussis A2 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 0.0001 5 20 25 5 144
B. petrussis Tox 6 stimulated immune cells (Stimulated PBMC) Stimulated PBMC 0.0001 5 20 25 5 144
Hepatocellular carcinoma (Liver cancer) Liver cancer 0.0001 43 70.4 61 104 207
Lymphoma or lymphoma cell line (B lymphoma) B lymphoma 0.0001 27 96.4 28 167 245
Lung carcinoid (Lung cancer) Lung cancer 0.0001 15 15.4 97 20 276
Large cell lung cancer (Lung cancer) Lung cancer 0.0001 4 11.7 34 4 276
B. petrussis stimulated immune cells (Stimulated PBMC) Stimulated PBMC 0.0002 20 80 25 67 144
Cancer and cell line (Gliomas*) Gliomas* 0.0002 28 4.2 657 47 1945
Cancer (Gliomas*) Gliomas* 0.0002 28 4.2 657 47 1945
CNS cancer or cell line (Gliomas*) Gliomas* 0.0002 28 4.2 657 47 1945
CNS tissue, cancer or cell line (Gliomas*) Gliomas* 0.0002 28 4.2 657 47 1945
CNS tumor (Gliomas*) Gliomas* 0.0002 28 4.2 657 47 1945
Atypical teratoid/rhabdoid tumour - CNS and other origin (Neuro tumors) Neuro tumors 0.0002 6 50 12 10 90
Follicular lymphoma (Various tumors) Various tumors 0.0002 9 14.0 64 9 154
Breast cancer cell line (Breast cancer) Breast cancer 0.0003 9 34.6 26 17 152


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Enriched GO annotations
For each GO annotation, we tested whether it was enriched in the set of genes of the module. Below we list all such annotations that were enriched in this module with an FDR corrected p-value of 0.05 ('P-value' column), along with the number ('Hits' column) of the module's genes in which they appear. We also show the fraction of the module's genes with the given GO annotation that are included in this module ('Hits (%)' column). For completeness, we also list the total number of genes in the module ('Module genes' column), total number of genes in the compendium in which the corresponding annotation is present ('Genes in annotation' column), and the total number of genes in the compendium ('Genes' column).
GO annotation P-value Hits Hits(%) Module genes Genes in annotation Genes
DNA replication 5.3e-06 14 4.5 309 52 4566
DNA dependent DNA replication 1.0e-05 10 3.2 309 29 4566
mitosis 1.7e-05 13 4.2 309 50 4566
S phase of mitotic cell cycle 2.9e-05 9 2.9 309 26 4566
nucleus 4.6e-05 94 30.4 309 966 4566
DNA metabolism 5.2e-05 26 8.4 309 169 4566
DNA replication and chromosome cycle 7.9e-05 9 2.9 309 29 4566
endomembrane system 0.0001 97 31.3 309 1029 4566


Jump to: Home | General properties | Gene sets | Enriched clinical annotations | Enriched Go annotations | Visual display
Visual display
Below is a visual display of the module. Shown are those arrays in which the module's genes significantly change, and the direction of change (induction/repression) in each array is indicated (middle, labeled 'Module changes'; red/green row). The arrays that correspond to the significant clinical attributes are also shown (top; brown rows). The gene sets that compose the module are also shown (left) along with an indication of the membership of the module genes in these gene sets.
You can also view the images within GeneXPress by loading the module gxp file file.
Note: Since there are 970 experiments, this image does not display the individual experiment names, but rather condenses each experiment to a single pixel without displaying its name. You can fully view the image for this module within GeneXPress, by loading any of the four files mentioned in the line above
 
 





 >4x